Activez les alertes d’offres d’emploi par e-mail !
A leading biotech company in Paris is seeking a PhD-level Translational Pharmacologist to contribute to preclinical studies. The role involves designing and executing experiments across various biological models. Candidates should have a strong background in microbiology and experience with rodent models, as well as the ability to communicate findings effectively. This position is critical for advancing breakthrough therapies in microbiome research.
Eligo Bioscience, backed by top-tier investors from Silicon Valley and Europe, is pioneering next-generation microbiome therapeutics. Co-founded by MIT and Rockefeller University scientists, Eligo is headquartered in Paris, France. Our mission is to address unmet medical needs in inflammatory and infectious diseases, as well as oncology, through groundbreaking gene-editing medicines.
Our first-in-class synthetic biology platform has earned Eligo numerous international awards and recognition, including being named one of the World Economic Forum’s “30 Most Innovative Companies” and has been featured in international press Nature, Science, The Economist, BBC, The New York Times, etc.
More recently, our latest work was published in Nature last year (In situ targeted base editing of bacteria in the mouse gut).
As part of the Translational Pharmacology team, you will contribute to the generation of pivotal preclinical data to support the development of Eligo’s programs towards the clinic.
You will join a team of translational scientists with strong experience in the setup and execution of in vitro, ex vivo and in vivo models across various fields (immunology, microbiology, molecular biology, pharmacology) to support the preclinical development of Eligo’s programs either internally or in collaboration with external partners. You will report to the translational pharmacology team lead.
Technical skills
Must have:
Nice to have: